Experiment 68506
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | MONTANER,JSG: GILL,J: SINGER,J: RABOUD,J: ARSENEAU,R: MC LEAN,BD: SCHECHTER,MT: RUEDY,J:. (1996). DOUBLE-BLIND PLACEBO-CONTROLLED PILOT TRIAL OF ACEMANNAN IN ADVANCED HUMAN IMMUNODEFICIENCY VIRUS DISEASE.. 12(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | DOUBLE-BLIND PLACEBO CONTROLLED PILOT TRIAL OF ACEMANNAN IN ADVANCED HUMAN IMMUNODEFICIENTY VIRUS DISEASE. RESULTS SHOWED THAT ACEMANNAN AT AN ORAL DAILY DOSE OF 1600 MG DOSES NOT PREVENT THE DECLINE IN CD4. |
| Dose amount | 400.0 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | MALE |